Test: Jurickson Profar’s 162-Game Suspension Reveals a Contractual Catch
The test that removed Jurickson Profar from competition was a positive result for exogenous testosterone, and Major League Baseball has suspended him for 162 games—an action that will cost him the entire 2026 season, including the playoffs, and thrust the Braves into urgent roster and payroll decisions.
What is not being told about the Test and the penalty?
Major League Baseball announced a 162-game suspension after Profar tested positive for exogenous testosterone. This is Profar’s second career PED suspension; he missed 80 games last year after testing positive for Chorionic Gonadotropin. Because this is a repeat violation, the suspension is not stayed and goes into effect on Friday, removing him from the 2026 season immediately. The Players Association plans to file a grievance challenging the suspension, and MLB has said the disciplinary process will be expedited to reach a final resolution.
What does the evidence and documentation show?
Key documentary facts available now: Major League Baseball announced the substance at issue as exogenous testosterone and set the penalty at 162 games. The decision eliminates Profar’s participation in the 2026 season and the postseason. The Braves released a statement expressing that they were “incredibly disappointed” to learn that Profar tested positive and noting that players receive consistent education on the drug-prevention program and its consequences. The Players Association has signaled it will contest the suspension through a grievance process while MLB moves to finalize the case quickly under the league’s policies for repeat violations.
Contractually, the suspension carries immediate financial consequences: Profar will not be paid his $15 million salary for the 2026 season if the suspension stands. He was entering the second season of a three-year, $42 million contract and was owed a $15 million salary in the contract’s final year. Last year’s suspension cost him just under $6 million of his $12 million salary in year one of that deal. Under the program’s escalation, a third positive test in Profar’s career would trigger a lifetime ban.
Who benefits, who is implicated, and what should the public expect?
Stakeholders are starkly defined. Major League Baseball has enforced the league’s drug-prevention policy with a maximum-season penalty for a repeat offense. The Players Association is positioned to defend a member through a grievance, seeking procedural relief or a reduced sanction. The Braves face an immediate practical problem: they must adjust a roster and payroll mid-contract for a player who will miss an entire season, and front-office choices will determine whether Profar remains on the roster or is moved in some other fashion. Profar himself stands to lose salary and the opportunity to play, and he is barred from representing the Netherlands in the upcoming World Baseball Classic while the suspension is in force.
What these facts mean together is a compressed accountability cycle: the league imposed its most severe in-season penalty for a repeat violation and accelerated adjudication; the union has signaled it will use grievance mechanisms; and the team must respond to the immediate competitive and financial fallout. At the same time, the pathway for reversal is narrow—appeals of PED cases are rarely successful—and a final outcome will hinge on the expedited process the league has described.
The unanswered operational questions are concrete and narrow: Will the Braves retain Profar on their payroll and roster after the grievance is filed, or will they seek roster and contractual remedies? How will expedited adjudication resolve factual and procedural issues raised by the Players Association? For fans and league observers, the central public-interest point is clarity: the league’s enforcement, the union’s challenge, and the team’s roster moves must be documented and disclosed with precision so the public can understand how PED policy, contract commitments, and competitive fairness interact around a single high-profile case.
Accountability requires full transparency on test protocols, chain of custody, and the steps MLB and the Players Association take during expedited review. The test that triggered this suspension has transformed a single positive result into a season-long absence, a significant payroll impact, and a test of institutional process that will conclude only when the grievance and league discipline reach a final disposition.
